Comparing endovascular and open reconstruction for TASC-II D aortoiliac disease: a propensity score analysis

Authors

  • Mariana Basílio-Martins Faculdade de Medicina da Universidade do Porto, Portugal
  • António Pereira-Neves Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Biomedicine, Unit of Anatomy, Faculdade de Medicina da Universidade do Porto, Portugal
  • Diogo Domingues-Monteiro Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Surgery and Physiology, Faculdade de Medicina da Universidade do Porto, Portugal
  • Tiago Costa-Pereira Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário de São João, Porto, Portugal
  • Mário Marques-Vieira Department of Angiology and Vascular Surgery, Hospital de Braga, EPE, Portugal
  • José Vidoedo Department of Angiology and Vascular Surgery, Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal
  • João Rocha-Neves Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Biomedicine, Unit of Anatomy, Faculdade de Medicina da Universidade do Porto, Portugal

DOI:

https://doi.org/10.18203/2349-2902.isj20233920

Keywords:

Peripheral artery disease, Aortobifemoral bypass, Aortoiliac stenting, Major adverse cardiovascular events, Preoperative care, Survival analysis

Abstract

Background: Aortoiliac disease management remains a subject of ongoing debate, with a shift in focus toward endovascular techniques, even in complex cases. This study aimed to evaluate and compare the safety and results of open surgery with endovascular surgery for treating TASC-II D aortoiliac lesions.

Methods: From January 2013 to February 2021, the clinical data of 89 patients revascularized with symptomatic TASC ΙΙ D AID were analyzed in a prospective cohort study. The patients were divided into two groups: open repair (61 patients) and endovascular treatment (28 patients). Baseline characteristics, preoperative and postoperative imaging, operation procedure reports and follow-up were reviewed and analyzed. Kaplan-Meier survival analysis, multivariate Cox regression, and a Propensity Score Matching (PSM) analysis were used to evaluate the relevance between risk factors and surgical technique.

Results: Open repair had a higher technical success rate (100% vs. 73.7%, p=0.01). 30-day major adverse cardiovascular (MACE) and limb (MALE) events showed no differences between both groups (PSM: 1 (4.8%) vs. 0, p=0.462 and 1 (4.8%) vs. 2 (13.3), p=0.235, respectively). Cox multivariable regression proportional hazard ratio showed no significant differences in terms of MALE between open and endovascular revascularization at 36 months (hazard ratio, HR 1.31 95% CI 0.56-3.06, p=0.54), even after PSM (HR 1.63 95% CI 0.58-4.55, p=0.35). Moreover, MACE and all-cause mortality also didn´t show a statistically significant difference between groups (HR 0.77 95% CI 0.22-2.64, p=0.67 and HR 0.97 95% CI 0.27-3.46, p=0.96).

Conclusions: Open and endovascular techniques are safe and effective treatments for complex AIOD. It is expected to have a higher technical success rate with open repair; however, there are no significant differences in MACE or MALE between these two approaches.

 

References

Pascarella L, Aboul Hosn M. Minimally Invasive Management of Severe Aortoiliac Occlusive Disease. J Laparoendosc Adv Surg Tech A. 2018;28(5):562-8.

Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg. 2010;52(5):1376-83.

Schneider PA. Endovascular or open surgery for aortoiliac occlusive disease? Cardiovasc Surg. 2002; 10(4):378-82.

Pulli R, Dorigo W, Fargion A, Innocenti AA, Pratesi G, Marek J, Pratesi C. Early and long-term comparison of endovascular treatment of iliac artery occlusions and stenosis. J Vasc Surg. 2011;53(1):92-8.

Miyamoto N, Kawasaki R, Fukuda T, Yamaguchi M, Sugimura K, Sugimoto K. Endovascular treatment for unilateral chronic total occlusions of the iliac artery categorized as TASC II type D lesions. Surg Today. 2015;45(2):162-7.

Aihara H, Soga Y, Mii S, Okazaki J, Yamaoka T, Kamoi D, et al. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. Circ J. 2014;78(2):457-64.

Rocha-Neves J, Ferreira A, Sousa J, Pereira-Neves A, Vidoedo J, Alves H, et al. Endovascular Approach Versus Aortobifemoral Bypass Grafting: Outcomes in Extensive Aortoiliac Occlusive Disease. Vasc Endovascular Surg. 2020;54(2):102-10.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(1): S1-75.

Agha R, Borrelli M, Vella-Baldacchino M, Thavayogan R, Orgill D, Group S. The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery. Int J Surg. 2017;46:198-202.

Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016;64(1):e1-21.

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816.

Pereira-Macedo J, Machado N, Pereira-Neves A, Ferreira V, Oliveira-Pinto J, Dias-Neto M, et al. Myocardial injury after aortoiliac revascularization for extensive disease: A survival analysis. Turk Gogus Kalp Damar Cerrahisi Derg. 2020;28(3):426-34.

Amanvermez Senarslan D, Yildırım F, Bayram B, Kurdal AT, Tetik O. Results of endovascular treatments of Trans-Atlantic Inter-Society Consensus C or D aortoiliac occlusive disease involving the aortic bifurcation. SAGE Open Med. 2023;11:205.

Smith SL, Matthews EO, Moxon JV, Golledge J. A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease. J Vasc Surg. 2019;70(3):996-1006.

Nobrega L, Pereira-Neves A, Duarte-Gamas L, Dias PP, Azevedo-Cerqueira A, Ribeiro H, et al. Outcome Analysis Using the Modified Frailty Index-5 in Patients With Complex Aortoiliac Disease. Ann Vasc Surg. 2022;79:153-61.

Visser L, Banning LBD, El Moumni M, Zeebregts CJ, Pol RA. The Effect of Frailty on Outcome After Vascular Surgery. Eur J Vasc Endovasc Surg. 2019; 58(5):762-9.

Della Schiava N, Naudin I, Bordet M, Arsicot M, Tresson P, Giai J, et al. Analysis of Preoperative CT Scan Can Help Predict Technical Failure of Endovascular Treatment of TASC C-D Aortoiliac Chronic Total Occlusions. Ann Vasc Surg. 2021;72: 276-83.

Squizzato F, D'Oria M, Bozza R, Porcellato L, Grego F, Lepidi S. Propensity-Matched Comparison of Endovascular versus Open Reconstruction for TASC-II C/D AortoIliac Occlusive Disease. A Ten-Year Single-Center Experience with Self-Expanding Covered Stents. Ann Vasc Surg. 2021;71:84-95.

Mayor J, Branco BC, Chung J, Montero-Baker MF, Kougias P, Mills JL, Sr., Gilani R. Outcome Comparison between Open and Endovascular Management of TASC II D Aortoiliac Occlusive Disease. Ann Vasc Surg. 2019;61:65-71.

Smith AH, Beach JM, Dash S, Rowse J, Parodi FE, Kirksey L, et al. Comparison of Aortobifemoral Bypass to Aortoiliac Stenting with Bifurcation Reconstruction for TASC II D Aortoiliac Occlusive Disease. Ann Vasc Surg. 2022;82:120-30.

Salem M, Hosny MS, Francia F, Sallam M, Saratzis A, Saha P, et al. Management of Extensive Aorto-Iliac Disease: A Systematic Review and Meta-Analysis of 9319 Patients. Cardiovasc Intervent Radiol. 2021;44(10):1518-35.

Downloads

Published

2023-12-27

Issue

Section

Original Research Articles